Clinical Trial

A Study to Assess Growth in Children With Idiopathic Short Stature

Recruiting
View on ClinicalTrials.gov →
Summary
Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-03-07; most recent amendment 2026-06-18.
Trial Details
NCT Number NCT06309979
Lead Sponsor BioMarin Pharmaceutical
Conditions Idiopathic Short Stature
Enrollment 300 participants
Start Date 2024-08-08
Primary Completion 2040-12-31 (estimated)
Study Completion 2040-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-23